- Report
- January 2026
- 160 Pages
Global
From €3018EUR$3,358USD£2,620GBP
€3551EUR$3,950USD£3,082GBP
- Report
- October 2025
- 160 Pages
Global
From €3018EUR$3,358USD£2,620GBP
€3551EUR$3,950USD£3,082GBP
- Report
- October 2025
- 160 Pages
Global
From €3018EUR$3,358USD£2,620GBP
€3551EUR$3,950USD£3,082GBP
- Report
- August 2025
- 150 Pages
Global
From €2942EUR$3,273USD£2,553GBP
€3461EUR$3,850USD£3,004GBP
- Report
- August 2025
- 150 Pages
Global
From €3018EUR$3,358USD£2,620GBP
€3551EUR$3,950USD£3,082GBP
- Report
- February 2026
- 82 Pages
Global
From €3500EUR$4,171USD£3,145GBP
- Report
- October 2025
- 135 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- October 2025
- 192 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- September 2025
- 125 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- February 2026
- 190 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- January 2026
- 211 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- January 2026
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- January 2026
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- January 2026
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- November 2025
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- October 2025
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- October 2025
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- November 2025
- 191 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- November 2025
- 109 Pages
Global
From €3101EUR$3,450USD£2,692GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more